Explore Annogen’s News
Major acceleration of Annogen’s SuRE technology in seed and ag-biotech sector
Annogen today announced a research collaboration with Orchard Therapeutics, a global gene therapy leader, for the identification of immune cell-specific human promoters for use in certain pre-clinical hematopoietic stem cell (HSC) gene therapy programs.
Annogen is heading to ESGCT 2025!
Annogen today announced a research collaboration with Orchard Therapeutics, a global gene therapy leader, for the identification of immune cell-specific human promoters for use in certain pre-clinical hematopoietic stem cell (HSC) gene therapy programs.
Lentitek and Annogen join forces to improve the quality and safety of T-cell therapies
Annogen today announced a research collaboration with Orchard Therapeutics, a global gene therapy leader, for the identification of immune cell-specific human promoters for use in certain pre-clinical hematopoietic stem cell (HSC) gene therapy programs.
T-cell promoter data presented at CGTI Leadership Summit
Annogen today announced a research collaboration with Orchard Therapeutics, a global gene therapy leader, for the identification of immune cell-specific human promoters for use in certain pre-clinical hematopoietic stem cell (HSC) gene therapy programs.
Annogen announces successful identification of cell-specific promoters for Orchard Therapeutics’ preclinical gene therapy programs
Annogen today announced a research collaboration with Orchard Therapeutics, a global gene therapy leader, for the identification of immune cell-specific human promoters for use in certain pre-clinical hematopoietic stem cell (HSC) gene therapy programs.
Ascend Advanced Therapies and Annogen Collaborate to Improve AAV Production
Ascend Advanced Therapies and Annogen will combine their expertise in AAV biology, vector manufacturing and genetic engineering to improve the quality of recombinant AAV particles used in gene therapy applications.
Corteva Annogen collaborating on functional annotation to accelerate crop improvement
New collaboration in crop engineering Collaborating on functional annotation to accelerate crop improvement Corteva Agriscience™ and Annogen B.V. are working together to functionally annotate thousands of expression elements in maize. Leveraging Annogen's innovative...
Annogen invited to speak at CropIB 2025
We’re thrilled to share that our Founder & CEO, Joris van Arensbergen, has been invited to speak at the prestigious Crop Innovation and Business (CIB) Conference in Cologne, taking place from 30 March – 1 April 2025. Joris will be delivering a talk on Large-scale...
UCSF, Annogen Announce Collaboration to Identify Superior Treg-Specific Promoters
UCSF, Annogen Announce Collaboration to Identify Superior Treg-Specific Promoters Annogen, a leader in gene expression engineering, and the prestigious labs of Qizhi Tang and Brian Shy at University of California, San Francisco (UCSF) today announced a collaboration...
